Last updated on: 6/1/2009 | Author: ProCon.org

Joep Killestein, MD, PhD Biography

Title:
Multiple Sclerosis Researcher in the Department of Neurology at the MS Centre at VU Medical Centre in Amsterdam
Position:
Not Clearly Pro or Con to the question "Should Marijuana Be a Medical Option?"
Reasoning:

“The authors conducted a randomized, double-blind, placebo-controlled, twofold crossover study in 16 patients with MS who presented with severe spasticity to investigate safety, tolerability, and efficacy of oral Delta(9)-Tetrahydrocannabinol (THC) and Cannabis sativa plant extract. Both drugs were safe, but adverse events were more common with plant-extract treatment. Compared with placebo, neither THC nor plant-extract treatment reduced spasticity. Both THC and plant-extract treatment worsened the participant’s global impression.”

“Safety, Tolerability, and Efficacy of Orally Administered Cannabinoids in MS,” Neurology , May 2

Involvement and Affiliations:
  • Multiple Sclerosis (MS) Researcher, Department of Neurology, MS Centre, VU Medical Centre, Amsterdam, The Netherlands
Education:
  • MD, School unknown
  • PhD, School unknown
Other:
  • None found